Ignite Creation Date:
2025-12-24 @ 9:10 PM
Ignite Modification Date:
2026-01-29 @ 5:25 PM
Study NCT ID:
NCT02611804
Status:
COMPLETED
Last Update Posted:
2017-05-05
First Post:
2015-11-19
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled, Multicenter Study Comparing Diclofenac Sodium Gel, 3% to Solaraze® Gel, 3% in the Treatment of Actinic Keratosis on the Face or Bald Scalp
Sponsor:
Teva Pharmaceuticals USA
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-10
Start Date Type:
None
Primary Completion Date:
2016-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-08
Completion Date Type:
ACTUAL
First Submit Date:
2015-11-19
First Submit QC Date:
None
Study First Post Date:
2015-11-23
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-05-03
Last Update Post Date:
2017-05-05
Last Update Post Date Type:
ACTUAL